Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimers disease
In the OASIS-4 trial, people with obesity taking the 25 mg oral semaglutide pill once a day, in addition to making lifestyle changes, lost about 16.6 percent of their body weight over 64 weeks, compared to 2.7 percent with placebo, says LaValle
Behavioural support such as keeping a food diary, setting realistic weekly goals, or accessing NHS weight management programmes can also significantly improve long-term adherence
Retatrutide, a groundbreaking medication, has emerged as a transformative tool that offers hope for individuals struggling with weight management and diabetes
Skin Harmony Say goodbye to uneven skin tone and dark spots
Initial dose: 0.25 mg once weekly Increase to 0.5 mg at four weeks Potentially increase to 1.0 mg at eight weeks Maintenance dose up to 2.4 mg weekly, based on individual response Every step of the semaglutide weight loss program is watched by healthcare professionals
